In situ analyses of genome instability in breast cancer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [145]
In the citing paper
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [353]
In the citing paper
“telomeres were shown to be shorter in invasive cancers Telomeres and telomerase in cancer of the breast, prostate and pancreas, as well as in their pre-invasive counterparts (123-126).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [124]
In the citing paper
“Recent observations indicate that both telomere dysfunction73, 74 and the DDR75, 76 are activated at the earliest stages in many human carcinomas.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [73]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829 · cited 1×
“This may explain why the risk of developing invasive cancer in individuals with UDH is only modestly increase”
BackgroundTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999 · cited 1×
“We analyzed genome copy-number changes using array CGH as described previousl”
MethodSelf-citationRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798 · cited 1×
“Most epithelial cells lack active telomerase, and so extended proliferation leads to telomere erosion and, eventually, loss of telomere functio”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 1×
“The molecular events that enable normal epithelial cells to progress to invasive, metastatic disease are increasingly well understoo”
BackgroundNormal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Self-citationERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Self-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“and are almost always eliminated by damage-surveillance mechanism”
Background
Cited by
Items 101–200 of 361
New tricks for an old fox: Impact of TGFβ on the DNA damage response and genomic stability
Barcellos-Hoff, M. H., & Cucinotta, F. A. (2014) · Science Signaling · doi:10.1126/scisignal.2005474 · Cited by 73
“However, although some degree of instability appears to promote tumorigenesis, cancer cells that have high GIN fail to progress (79).”
BackgroundCerone, M. A., Londoño‐Vallejo, A., & Autexier, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0033 · Cited by 79
Amplification of zinc finger gene 217 (ZNF217) and cancer: When good fingers go bad
Quinlan, K. G. R., Verger, A., Yaswen, P., & Crossley, M. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.001 · Cited by 77
Self-citationPampalona, J., Soler, D., Genescà, A., & Tusell, L. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.10.001 · Cited by 69
Garbe, J. C., Vrba, L., Sputova, K., Fuchs, L., Novák, P., Brothman, A. R., Jackson, M. W., Chin, K., LaBarge, M. A., Watts, G. S., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.954456 · Cited by 75
“CGH for the 184F lines was performed as described.(5) Karyology was performed as described.”
BackgroundMethodInfluentialSelf-citationChromosomal Instability in Barrett's Esophagus Is Related to Telomere Shortening
Finley, J. C., Reid, B. J., Odze, R. D., Sanchez, C. A., Galipeau, P. C., Li, X., Self, S. G., Gollahon, K. A., Blount, P. L., & Rabinovitch, P. S. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0837 · Cited by 82
“In the human breast, telomere lengths have been reported to progressively shorten from atypical ductal hyperplasia to ductal carcinoma in situ to invasive cancer, but CIN appeared highest in ductal carcinoma in situ , suggesting that telomere-mediated CIN may be most critical in the ductal hyperplasia to ductal carcin…”
BackgroundShared environmental factors associated with telomere length maintenance in elderly male twins
Huda, N., Tanaka, H., Herbert, B., Reed, T., & Gilley, D. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00330.x · Cited by 67
Molecular Markers for the Diagnosis and Management of Ductal Carcinoma In Situ
Polyák, K. (2010) · JNCI Monographs · doi:10.1093/jncimonographs/lgq019 · Cited by 72
“Although the molecular mechanisms underlying intratumor diversity are poorly defined, genomic instability because of telomere shortening and subsequent telomere crisis that is observed at the DCIS stage is one of the potential explanations (22).”
BackgroundTelomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 74
“Furthermore, the transition from usual ductal hyperplasia to invasive cancer is accompanied by telomere-driven genomic aberrations (Chin et al. 2004).”
BackgroundTelomere dysfunction drives chromosomal instability in human mammary epithelial cells
Soler, D., Genescà, A., Arnedo, G., Egozcue, J., & Tusell, L. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20244 · Cited by 72
“…been observed that the genomic events occurring in cultures of HMECs before, during, and after ZNF217-mediated immortalization were remarkably similar to those occurring in breast cancer during progression from usual ductal hyperplasia (UGH) to ductal carcinoma in situ (DCIS) (Chin et al., 2004).”
BackgroundResultInfluentialLo, P., Zhang, Y., Yao, Y., Wolfson, B., Yu, J. E., Han, S., Duru, N., & Zhou, Q. Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775080 · Cited by 72
“While global profiling of genetic and gene expression alterations in DCIS and IDC has revealed a high level of similarity between them, researchers have so far failed to identify the key mechanisms driving the invasive transition (3-5).”
BackgroundChromosome instability in neoplasia: chaotic roots to continuous growth
Gagos, S., & Irminger‐Finger, I. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.01.003 · Cited by 78
Allele-specific relative telomere lengths are inherited
Graakjær, J., Der‐Sarkissian, H., Schmitz, A., Bayer, J. A., Thomas, G. D., Kølvraa, S., & Londoño‐Vallejo, A. (2006) · Human Genetics · doi:10.1007/s00439-006-0137-x · Cited by 73
“For example, in vivo, short telomeres are often observed in early stages of tumor development and their presence correlates with the occurrence of genomic instability (Chin et al. 2004; Meeker et al. 2004).”
BackgroundElse, T., Trovato, A., Kim, A. C., Wu, Y., Ferguson, D. O., Kuick, R. D., Lucas, P. C., & Hammer, G. D. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.011 · Cited by 62
“Our studies of the Acd p53 / mouse model reproduce the genomic alterations proposed by the telomere-based model of carcinogenesis (Chin et al., 2004; O’Hagan et al., 2002).”
BackgroundBreast cancer genomes — form and function
Korkola, J. E., & Gray, J. W. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.005 · Cited by 85
“Fluorescence in situ hybridization (FISH) provides information about copy number and structural heterogeneity including variation between cells and in histological context [3].”
BackgroundSelf-citationTelomere dysfunction and genome instability
Frias, C. (2012) · Frontiers in Bioscience · doi:10.2741/4044 · Cited by 61
Big Bang Tumor Growth and Clonal Evolution
Sun, R., Hu, Z., & Curtis, C. N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028381 · Cited by 64
“Moreover, telomere crisis has been reported to cause elevated genomic instability during early tumor progression, which then decreases once telomerase function is restored (Chin et al. 2004).”
BackgroundProstatic preneoplasia and beyond
Joshua, A. M., Evans, A., van der Kwast, T., Zieleńska, M., Meeker, A. K., Chinnaiyan, A. M., & Squire, J. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.12.001 · Cited by 80
Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain
Andriani, G. A., Vijg, J., & Montagna, C. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.007 · Cited by 57
“Evidence generated using in vitro models supports the hypothesis that the origin of cytogenetic alterations may be concurrent with telomere crisis (Chin et al., 2004).”
BackgroundTrková, M., Procházková, K., Krutilkova, V., Sumerauer, D., & Sedláček, Z. (2007) · Cancer · doi:10.1002/cncr.22834 · Cited by 61
Thillainadesan, G., Isovic, M., Loney, E. R., Andrews, J. D., Tini, M., & Torchia, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00246-08 · Cited by 64
“In addition, prolonged growth of ZNF217-immortalized cells results in chromosomal instability, as well as telomere crisis and telomerase reactivation (9).”
BackgroundHuman rDNA copy number is unstable in metastatic breast cancers
Valori, V., Tus, K., Laukaitis, C. M., Harris, D. T., LeBeau, L. G., & Maggert, K. A. (2019) · Epigenetics · doi:10.1080/15592294.2019.1649930 · Cited by 60
“Breast cancers, along with leukemias and lymphomas, colorectal cancers, and others, are known to involve expansive genome instability, including chromosome aneuploidies and rearrangements (Richard et al. 2000; Chin et al. 2004; Storchova and Pellman 2004; de Vargas Wolfgramm et al. 2013).”
BackgroundIakovlev, V. V., Arneson, N. C. R., Wong, V., Wang, C., Leung, S., Iakovleva, G., Warren, K., Pintilie, M., & Done, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4960 · Cited by 53
Telomere fusions in early human breast carcinoma
Tanaka, H., Abe, S., Huda, N., Tu, L., Beam, M. J., Grimes, B., & Gilley, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120062109 · Cited by 52
“Several studies have reported that anaphase bridges, possibly formed as a consequence of telomere dysfunction, are present in early-stage tumors, including DCIS (7, 10, 11).”
BackgroundChromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns
Watson, E. V., Lee, J. J.-K., Gulhan, D., Melloni, G. E. M., Venev, S. V., Magesh, R. Y., Frederick, A., Chiba, K., Wooten, E. C., Naxerova, K., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01665-2 · Cited by 61
“Yet , aneuploidy emerges early during tumorigenesis, appearing in pre-cancerous neoplasms 10–12 , increasing in degree as disease stage advances 13–15 .”
Multiscale Models of Breast Cancer Progression
Chakrabarti, A., Verbridge, S. S., Stroock, A. D., Fischbach, C., & Varner, J. D. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0655-8 · Cited by 58
Tolerance of Chromosomal Instability in Cancer: Mechanisms and Therapeutic Opportunities
Gronroos, E. C., & López-García, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1958 · Cited by 71
Knowles, D. W., Sudar, D., Bator-Kelly, C. M., Bissell, M. J., & Lelièvre, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509944102 · Cited by 51
Self-citationLi, A., Keck, J. M., Parmar, S. S., Patterson, J., Labrie, M., Creason, A., Johnson, B., Downey, M., THOMAS, G. V., Beadling, C., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00165-4 · Cited by 53
Self-citationTumor microenvironment and breast cancer progression: A complex scenario
Artacho-Cordón, A., Artacho‐Cordón, F., Ríos‐Arrabal, S., Calvente, I., & Núñez, M. I. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18869 · Cited by 59
“Based on these assumptions, several groups performed comprehensive gene expression and genetic profiling studies to compare among in situ, invasive, and metastatic breast carcinomas, but they failed to identify any tumor stage–specific gene signatures.(25) However, they focused mainly on tumor epithelial cells and the…”
MethodWhole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation
Manning, A. L., Benes, C. H., & Dyson, N. J. (2013) · Oncogene · doi:10.1038/onc.2013.201 · Cited by 54
DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer
Raynaud, C. M., Hernandez, J., Llorca, F. P., Nuciforo, P., Mathieu, M.-C., Commo, F., Delaloge, S., Sabatier, L., André, F., & Soria, J.-C. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181b0c4c2 · Cited by 48
“These data are consistent with several reports indicating that telomeric crisis and telomeric aberration occur after the preneoplastic stage, when DDR fails to control genomic aberration.(15) Chin et al showed that transition through telomere crisis and immortalization in breast cancer occurs during the progression fr…”
Bartocci, C., Diedrich, J. K., Ouzounov, I., Li, J., Piunti, A., Pasini, D., Yates, J. R., & Lazzerini Denchi, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.002 · Cited by 49
“…human cancers such as colorectal carcinomas (Rudolph et al., 2001), oral squamous cell carcinomas (Gordon et al., 2003), and chronic lymphocytic leukemia (Augereau et al., 1320 Cell Reports 7, 1320–1332, May 22, 2014 ª2014 The Authors 2011; Chin et al., 2004; Lin et al., 2010; Suram et al., 2012).”
BackgroundSEL1L a multifaceted protein playing a role in tumor progression
Biunno, I., Cattaneo, M., Orlandi, R., Canton, C., Biagiotti, L., Ferrero, S., Barberis, M. C. P., Pupa, S. M., Scarpa, A., & Ménard, S. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20574 · Cited by 52
“The increased expression of chaperone proteins (Hps70,Hps90, Hps27) over the level seen in normal tissues seems to be a common finding in many human cancers, both solid and hematologic malignancies (Conroy et al., 1998; Vargas-Roig et al., 1998; Ciocca and Calderwood, 2005).”
BackgroundLi, Y., Pan, J., Li, J.-L., Lee, J. H., Tunkey, C., Saraf, K., Garbe, J. C., Whitley, M. Z., Jelinsky, S. A., Stampfer, M. R., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-7 · Cited by 50
Self-citationMarella, N. V., Malyavantham, K. S., Wang, J., Matsui, S., Liang, P., & Berezney, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0420 · Cited by 48
“Chromosomal aberrations such as amplifications, deletions, and complex chromosomal translocations are a hallmark of solid tumors and are generally believed to occur via telomere dysfunction and the breakage-fusion-bridge mechanism (48).”
BackgroundTelomeres and genomic evolution
Baird, D. M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0437 · Cited by 54
“There are good data from human cancers demonstrating telomere erosion to the lengths observed in cells undergoing crisis in culture, as well as telomere fusion and evidence of anaphase-bridging [8, 9, 52-55].”
Thollet, A., Vendrell, J. A., Payen, L. F., Ghayad, S. E., Larbi, S. B., Grisard, E., Collins, C. C., Villedieu, M., & Cohen, P. A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-291 · Cited by 58
“It has been hypothesized that the selective amplification of ZNF217 allows cancer cells to overcome senescence and become immortal, a requirement likely essential for cancer development [8].”
BackgroundIntegrating the multiple dimensions of genomic and epigenomic landscapes of cancer
Chari, R., Thu, K. L., Wilson, I. M., Lockwood, W. W., Lonergan, K. M., Coe, B. P., Malloff, C. A., Gazdar, A. F., Lam, S. C., Garnis, C., et al. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9199-2 · Cited by 57
“aberrations and telomere dysfunction play key causative roles [51–55].”
BackgroundRauser, S., Weis, R., Braselmann, H., Feith, M., Stein, H. J., Langer, R., Hutzler, P., Hausmann, M., Laßmann, S., Siewert, J. R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0465 · Cited by 47
Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients
Simpson, K., Jones, R. E., Grimstead, J. W., Hills, R., Pepper, C., & Baird, D. M. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.003 · Cited by 46
“In addition to providing prognostic resolution, our telomere-length data imply that telomere dysfunction is important in the pathogenesis of breast cancer, a view that is consistent with data from other laboratories (Chin et al., 2004; Tanaka et al., 2012).”
BackgroundResultMcCullough, D. P., Gudla, P. R., Harris, B. S., Collins, J. A., Meaburn, K. J., Nakaya, M., Yamaguchi, T. P., Misteli, T., & Lockett, S. (2008) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2007.913135 · Cited by 46
“Examples include understanding genetic variations from cell to cell that arise in solid tumors [ 37 ], interactions between drug-resistant and drug-sensitive cells [38], and cell polarity in tissue development and homeostasis [1].”
BackgroundSelf-citationMammary carcinoma behavior is programmed in the precancer stem cell
Damonte, P., Hodgson, J. G., Chen, J. Q., Young, L. J. T., Cardiff, R. D., & Borowsky, A. D. (2008) · Breast Cancer Research · doi:10.1186/bcr2104 · Cited by 48
“The 'telomere crisis' hypothesis [15,20] is supported, in part, by our studies.”
Telomere‐mediated genomic instability and the clinico‐pathological parameters in breast cancer
Poonepalli, A., Banerjee, B., Ramnarayanan, K., Palanisamy, N., Putti, T. C., & Hande, M. P. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20608 · Cited by 51
“Genomic instability contributes to a major problem in management of breast cancer phenotypes because of their more aggressive phenotype and chemo-resistance (Loeb, 2001; Chin et al., 2004).”
BackgroundKim, S., Sandler, D. P., Carswell, G. K., DeRoo, L. A., Parks, C. G., Cawthon, R., Weinberg, C. R., & Taylor, J. A. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9778-8 · Cited by 43
“carcinoma in situ and invasive cancer) compared with normal ductal epithelium [5, 6].”
BackgroundBanys-Paluchowski, M. J., Gruber, I. V., Krawczyk, N., Becker, S., Kurth, R., Wallwiener, D. R., Jakubowska, J., Hoffmann, J., Rothmund, R., Staebler, A., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1478-2 · Cited by 43
“Moreover, it has been shown that chromosomal instability occurs in breast cancer before histologic cancer invasion [17].”
BackgroundWang, Y., Hu, Z., Liang, J., Wang, Z., Tang, J., Wang, S., Wang, X., Qin, J., Wang, X., & Shen, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn099 · Cited by 45
Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
Cuceu, C., Hempel, W. M., Sabatier, L., Bosq, J., Carde, P. P., & M’kacher, R. (2018) · Cancers · doi:10.3390/cancers10040091 · Cited by 42
Trinh, A., del Alcazar, C. R. G., Shukla, S. A., Chin, K., Chang, Y. H., Thibault, G., Eng, J. R., Jovanović, B., Aldaz, C. M., Park, S. Y., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0949 · Cited by 46
“TP53 mutation, genomic instability and telomere crisis are more 468 common in ER DCIS and have been associated with higher TILs which could be recruited following 469 activation of the cGAS-STING pathway mediated by cytosolic double-stranded DNA (47,60,61).”
BackgroundResultInfluentialSelf-citationMolecular profile of atypical hyperplasia of the breast
Danforth, D. N. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4488-x · Cited by 41
The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells
Castro‐Vega, L. J., Jouravleva, K., Ortíz-Montero, P., Liu-Bordes, W.-Y., Galeano, J. L., Romero, M. L., Popova, T. G., Bacchetti, S., Vernot, J., & Londoño‐Vallejo, A. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv101 · Cited by 45
“In the multistep carcinogenesis model, telomere shortening has been observed together with increased chromosome instability (CIN) in early precancerous conditions [7] [8] [9].”
BackgroundTelomeres as hotspots for innate immunity and inflammation
Nassour, J., Przetocka, S., & Karlseder, J. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103591 · Cited by 42
Mechanisms of telomeric instability
Baird, D. M. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167817 · Cited by 44
Is Breast Tumor Progression Really Linear?
Polyák, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2188 · Cited by 40
Haakensen, V. D., Lingjærde, O. C., Lüders, T., Riis, M. L. H., Prat, A., Troester, M. A., Holmen, M. M., Frantzen, J. O., Romundstad, L., Navjord, D., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-77 · Cited by 40
“Breast carcinogenesis, with the transition of normal breast epithelial cells through hyperplasia to invasive cancer, is increasingly well understood [1,2], but there is uncertainty as to the exact mechanisms of tumour initiation and in which cells these first steps occur [3].”
BackgroundLi, K., Yan, H., Guo, W., Tang, M., Zhao, X., Tong, A., Peng, Y., Li, Q., & Yuan, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.006 · Cited by 38
Telomerase-dependent and -independent chromosome healing in mouse embryonic stem cells
Gao, Q., Reynolds, G. E., Wilcox, A., Miller, D. L., Cheung, P., Artandi, S. E., & Murnane, J. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.04.004 · Cited by 38
Prostate Cancer as a Model System for Genetic Diversity in Tumors
Squire, J. A., Park, P. C., Yoshimoto, M., Alami, J., Williams, J. L., Evans, A. J., & Joshua, A. M. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-387688-1.00007-7 · Cited by 40
Severson, P. L., Vrba, L., Stampfer, M. R., & Futscher, B. W. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.10.011 · Cited by 40
“We have used an in vitro human mammary epithelial cell (HMEC) model system that has proven useful for identifying and reflecting the genetic and epigenetic events involved in early human breast carcinogenesis [11-16].”
Self-citationMcLellan, J. L., O’Neil, N. J., Tarailo, S., Stoepel, J., Bryan, J., Rose, A. M., & Hieter, P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-08-0699 · Cited by 37
MiCroKiTS 4.0: a database of midbody, centrosome, kinetochore, telomere and spindle
Huang, Z., Ma, L., Wang, Y., Pan, Z., Ren, J., Liu, Z., & Xue, Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1125 · Cited by 38
“identified that transition through telomere crisis is crucial for the progression of breast cancers (28).”
BackgroundSarper, M., Allen, M. D., Gomm, J., Haywood, L., Decock, J. V., Thirkettle, S., Ustaoglu, A., Sarker, S., Marshall, J. F., Edwards, D. R., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0822-9 · Cited by 37
Loss of Telomere Protection: Consequences and Opportunities
Jacobs, J. J. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00088 · Cited by 48
“Moreover, in breast cancer the presence of short telomeres coincides with a sudden rise in genomic instability at the transition from ductal hyperplasia to carcinoma in situ and before the activation of telomerase (Chin et al., 2004).”
Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes
Heaphy, C. M., Subhawong, A. P., Gross, A. L., Konishi, Y., Kouprina, N., Argani, P., Visvanathan, K., & Meeker, A. K. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.198 · Cited by 36
Heterogeneity of mammary lesions represent molecular differences
Namba, R., Maglione, J. E., Davis, R. R., Baron, C. A., Liu, S., Carmack, C. E., Young, L. J. T., Borowsky, A. D., Cardiff, R. D., & Gregg, J. P. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-275 · Cited by 45
“Gene expression profiling and comparative genomic hybridization (CGH) studies of breast cancer demonstrate that early stages in the human breast cancer such as ductal carcinoma in situ (DCIS), a precursor lesion for invasive carcinoma, has most, if not all, of the molecular attributes of the corresponding invasive car…”
BackgroundMethodSmirnov, E., Chmúrčiaková, N., & Cmarko, D. (2021) · Cells · doi:10.3390/cells10123452 · Cited by 38
Soo, J. K., Ross, A. D. M., Kallenberg, D. M., Milagre, C. S., Chong, W. H., Chow, J. W. M., Hill, L. J., Hoare, S. F., Collinson, R. S., Hossain, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00850.x · Cited by 39
“Telomeric crisis has been described as a stage in the progression of human breast, pancreatic, colorectal, and other cancers (Chin et al., 2004; Hezel et al., 2006; Höglund et al., 2003; Rudolph et al., 2001).”
InfluentialDisruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis
Eng, J. R., Thibault, G., Luoh, S., Gray, J. W., Chang, Y. H., & Chin, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_24 · Cited by 37
Self-citationTelomere shortening in breast cancer correlates with the pathological features of tumor progression
Kammori, M., SUGISHITA, Y., Okamoto, T., Kobayashi, M., Yamazaki, K., Yamada, E., & Yamada, T. (2015) · Oncology Reports · doi:10.3892/or.2015.4063 · Cited by 38
Minimizing the risk of cancer: tissue architecture and cellular replication limits
Rodriguez-Brenes, I. A., Wodarz, D., & Komarova, N. L. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0410 · Cited by 38
“The link between telomeres and cancer is supported by the fact that most colonies of transformed human cells initially proliferate but ultimately cease to divide and die [8, 9].”
BackgroundBarcellos‐Hoff, M. H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.001 · Cited by 37
Banys-Paluchowski, M. J., Hahn, M., Gruber, I. V., Krawczyk, N., Wallwiener, M., Hartkopf, A. D., Taran, F., Röhm, C., Kurth, R., Becker, S., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2898-6 · Cited by 32
Ma, J., Gao, M., Lu, Y., Feng, X., Zhang, J., Lin, D., Xiao, T., Hu, Z., Yuan, J., Su, K., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2050 · Cited by 32
“This is in line with data from breast cancers, which show an increase in abnormalities associated with the transition from benign to malignant growth [34].”
ResultEvolution of genetic instability in heterogeneous tumors
Asatryan, A. D., & Komarova, N. L. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.11.028 · Cited by 37
“It has been argued by [13] that the level of genetic instability in breast cancers first increases, reaches a peak and then decreases as the cancer passes through telomere crisis.”
BackgroundLee, J. K., Garbe, J. C., Vrba, L., Miyano, M., Futscher, B. W., Stampfer, M. R., & LaBarge, M. A. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00013 · Cited by 32
“…based on antibiotic resistance, and the process of immortalization occurred en mass. Finally, we did not go beyond the non-malignant immortal stage of cancer progression, which best represents the stage of tumor cells in ductal carcinoma in situ lesions (Shpitz et al., 1999; Chin et al., 2004).”
BackgroundMethodSelf-citationShort telomeres are frequent in hereditary breast tumors and are associated with high tumor grade
Martínez–Delgado, B., Gallardo, M., Tanić, M., Yanowsky, K., Inglada‐Pérez, L., Barroso, A., Rodriguez-Pinilla, M. S., Cañamero, M., Blasco, M. A., & Benitez, J. J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2696-6 · Cited by 42
“It has been described that telomere shortening commonly occurs at initial steps of cancer transformation [4–9], and in addition may contribute to tumor progression in many cancer types including breast cancer [7, 10].”
BackgroundGonzález‐Moles, M. Á., Pino, C. K.-D., & Ramos‐García, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113099 · Cited by 34
“By this mechanism, reduced telomerase activity in the early stages of malignant transformation, in which only the functions of tumor-suppressor genes would fail, would facilitate by telomere shortening the acquisition of cancer-linked nonclonal chromosomal aberrations; later, telomerase activation would promote the su…”
BackgroundSfeir, A. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.106831 · Cited by 43
“Many solid tumors, including those of the breast (Chin et al., 2004), prostate (Meeker et al., 1996) and colon (Rudolph et al., 2001), have shorter telomeres when compared with those of the respective normal tissue.”
BackgroundJunk, D. J., Cipriano, R., Stampfer, M. R., & Jackson, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053776 · Cited by 30
Self-citationRegulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)
Scribner, K. C., Behbod, F., & Porter, W. W. (2012) · Oncogene · doi:10.1038/onc.2012.286 · Cited by 34
N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
Wu, Q., Fu, X., Liu, G., He, X., Li, Y., & Ou, C. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01665-7 · Cited by 33
Sudo, H., Garbe, J. C., Stampfer, M. R., Barcellos‐Hoff, M. H., & Kronenberg, A. (2008) · Radiation Research · doi:10.1667/rr1317.1 · Cited by 32
Self-citationGenotoxic risk of ethyl‐paraben could be related to telomere shortening
Finot, F., Kaddour, A., Morat, L., Mouche, I., Zaguia, N., Cuceu, C., Souverville, D., Négrault, S., Cariou, O., Essahli, A., et al. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3425 · Cited by 31
“Telomere erosion has been documented in breast cancer (Odagiri et al., 1994) and evidence of telomere shortening has been observed early in the progression of the disease (Chin et al., 2004; Meeker and Argani, 2004; Tanaka et al., 2012).”
BackgroundAn Integrated Human Mammary Epithelial Cell Culture System for Studying Carcinogenesis and Aging
Stampfer, M. R., LaBarge, M. A., & Garbe, J. C. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_15 · Cited by 31
Self-citationZNF365 Promotes Stability of Fragile Sites and Telomeres
Zhang, Y., Shin, S. J., Liu, D., Ivanova, E. V., Foerster, F., Ying, H., Zheng, H., Xiao, Y., Chen, Z., Protopopov, A. I., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0536 · Cited by 30
CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy
Mintz, R. L., Gao, M. A., Lo, K., Lao, Y., Li, M., & Leong, K. W. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800132 · Cited by 30
Chromothripsis and telomere crisis: engines of genome instability
Dewhurst, S. M. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.02.009 · Cited by 29
Chromosome 9 arm-specific telomere length and breast cancer risk
Zheng, Y., Loffredo, C. A., Shields, P. G., & Selim, S. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp151 · Cited by 27
Tang, M. E., Dahlgren, M., Brueffer, C., Tjitrowirjo, T., Winter, C., Chen, Y., Olsson, E., Wang, K., Törngren, T., Sjöström, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5951 · Cited by 27
“Regardless of the rearrangement pattern, the high rate of shared rearrangements between primary and metastasis is consistent with their early origin, potentially during a time of telomere crisis, where high proliferation already during ductal hyperplasia and carcinoma in situ leads to telomere erosion, chromosome fusi…”
The role of recombination in telomere length maintenance
Royle, N. J., Méndez-Bermúdez, A., Gravani, A., Novo, C. L., Foxon, J. L., Williams, J. P., Cotton, V. E., & Hidalgo, A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370589 · Cited by 37
Kumar, M., Lechel, A., & Güneş, Ç. (2016) · Genes · doi:10.3390/genes7080043 · Cited by 30
“Studies in a variety of human and mouse cancer models, including breast cancer, HCC, and prostate cancer provided evidence for the telomere hypothesis [77,84–89].”
BackgroundEpigenetic Changes During Cell Transformation
Futscher, B. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_9 · Cited by 29
Mukhopadhyay, R., Costes, S. V., Bazarov, A. V., Hines, W. C., Barcellos‐Hoff, M. H., & Yaswen, P. (2010) · Breast Cancer Research · doi:10.1186/bcr2477 · Cited by 30
“In previous studies, such vHMEC have been shown to be susceptible to genomic instability associated with telomere and centrosome dysfunction [6,13,14].”
BackgroundSelf-citationTRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
Brunori, M., Mathieu, N., Ricoul, M., Bauwens, S., Koering, C., de Climens, A. R., Belleville, A., Wang, Q., Puisieux, I., Décimo, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209135 · Cited by 29
“…Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc of telomere instability could occur at early stages as a consequence of an excessive telomere shortening and checkpoint inactivation (Rudolph et al., 2001; O’Sullivan et al., 2002; Chin et al., 2004; Zhang et al., 2004).”
BackgroundInfluentialA Novel Candidate Disease Genes Prioritization Method Based on Module Partition and Rank Fusion
Chen, X., Yan, G., & Liao, X. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0143 · Cited by 26
“For example, gene CDKN2A, which codes p16ink and p14ARF, regulates two critical cell cycle regulatory pathways: Rb and TP53.”
Castro‐Vega, L. J., Jouravleva, K., Liu-Bordes, W.-Y., Martinez, C., Gestraud, P., Hupé, P., Servant, N., Albaud, B., Gentien, D., Gad, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt029 · Cited by 29
“to occur at pre-invasive lesions of epithelial cancers (39,40), this is the first time that a connection between these two phenomena is firmly established.”
BackgroundWu, X., & Tanaka, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5083 · Cited by 28
“In summary, this study highlights the quantitative abnormality of plasma telomeric cfDNA observed in patients with pre-malignant DCIS.”
InfluentialDahlgren, P. N., Bishop, K., Dey, S., Herbert, B., & Tanaka, H. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.007 · Cited by 27
“It has been shown that telomeres are shorter in invasive tumors than in early stages of tumors [20,21].”
BackgroundRichard, V., Davey, M. G., Annuk, H., Miller, N., & Kerin, M. J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01506-y · Cited by 26
Metadata
- Authors
- Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., Miranda, M., Krig, S., Garbe, J., Stampfer, M., Yaswen, P., Gray, J. W., & Lockett, S. J.
- Affiliations
- University of California, San Francisco (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Gray, Joe W
- Venue
- Nature Genetics
- Published
- 2004-08-08
- Volume
- 36
- Issue
- 9
- Pages
- 984-988
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053300345
- Semantic Scholar
- 005930a6472117d3d08d09415087ec01d5c8ecb1
- Cited by
- 361
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 15 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 24 · 2012: 24
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Avon Foundation for Women
- Universiteit Leiden
- National Institutes of Health
- National Cancer Institute (R01CA101359, R01CA090421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- genomic instability, telomere crisis, breast cancer progression, ductal carcinoma in situ, usual ductal hyperplasia, mammary epithelial cells, ZNF217, cell immortalization, fluorescence in situ hybridization
- MeSH terms
- Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Humans, Hyperplasia, Tumor Cells, Cultured, Ultrasonography, Telomere, In Situ Hybridization, Carcinoma, Ductal, Breast, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.